Regulatory and Washington

WASHINGTON — Prescription-only pseudoephedrine laws result in well more than $278 million in additional burdens to taxpayers, according to a study published by Matrix Global Advisors on Monday. 

WASHINGTON — Club retailer Costco Wholesale is throwing its support behind a bill introduced in Congress Tuesday to raise the federal minimum wage.

ALEXANDRIA, Va. — The National Community Pharmacists Association on Wednesday joined the North Dakota Pharmacy Association in support of a pharmacy benefit manager transparency bill that was passed by the state assembly by a vote of 93-0 on Feb. 25. 

PARSIPPANY, N.J. — Drug maker Actavis is challenging the patent for a drug used to treat testosterone deficiency or absence in men, the company said.

Actavis, formerly known as Watson Pharmaceuticals, said it had filed a regulatory approval application with the Food and Drug Administration for a generic version of Endo Pharmaceuticals' Fortesta (testosterone) gel in the 10 mg-per-0.5 g strength.

WASHINGTON — Several senators have requested that the Government Accountability Office look for ways to coordinate the efforts of law enforcement and public health agencies at various levels and nonprofit organizations to address prescription drug abuse.

NEW YORK — The stakes are high in a case involving generic drug maker Actavis and the Federal Trade Commission that will soon go before the Supreme Court, the head of a generic drug industry lobbying group said in a conference call with reporters Tuesday.

The case, FTC v. Actavis, will go before the high court on March 25 and may decide the future of patent settlements between branded and generic drug companies. The Generic Pharmaceutical Association filed an amicus brief with the court last week defending the settlements as beneficial to consumers.

NEW YORK — Automatic spending cuts stemming from the failure of Congress and the White House to reach a budget deal will likely harm the disease-preventing capabilities of the Centers for Disease Control and Prevention, according to a new report.

GlobalData, a market research and analytics firm, said the slashing of the CDC's funding by $450 million, or 8%, due to the sequester would both hamper its ability to prevent infectious diseases through immunization, surveillance and response programs while also failing to accomplish the goal of decreasing federal spending.

ALEXANDRIA, Va. — The National Community Pharmacists Association on Friday submitted written comments urging the Centers for Medicare and Medicaid Services to take action on a wide range of what NCPA characterizes as "anti-patient, anti-pharmacist practices," the association announced.